U.S. Household Products Stock News

In the past quarter, Krystal Biotech, Inc. reported Q2 2026 net income of US$54.77 million, with basic earnings per share from continuing operations of US$1.85, up from US$38.33 million and US$1.33 a year earlier. Over the first half of 2026, net income rose to US$110.70 million and higher per-share earnings underscored the earnings power of Vyjuvek alongside an advancing gene therapy pipeline. We’ll now examine how this stronger profitability profile, anchored by Vyjuvek’s contribution,...

Earlier this month, ICON Investments Six Designated Activity Company priced US$2.15 billion of senior unsecured notes maturing between 2029 and 2036, with guarantees from ICON, to refinance its bridge facility, senior secured term loans and 5.809% senior secured notes due 2027. This refinancing is set to release collateral and subsidiary guarantees tied to ICON's existing debt, effectively shifting the group toward a fully unsecured capital structure. With ICON reshaping its balance sheet...

Viatris (VTRS) is back in focus after raising its 2026 earnings guidance alongside second quarter results that showed higher sales and revenue year on year, as well as a return to net profitability for the first half. See our latest analysis for Viatris. At a share price of US$16.23, Viatris has seen some short term softness with a 1 month share price return of 2.7% and a 3 month share price return of 1.5%. At the same time, the year to date share price return of 30.26% sits alongside a 1...

First Advantage (FA) has drawn investor attention after reporting second quarter 2026 sales of US$448.76 million and net income of US$16.91 million, along with higher full year revenue guidance supported by broad-based customer demand. See our latest analysis for First Advantage. At a share price of US$21.58, First Advantage has had a 90 day share price return of 45.12% and a year to date share price return of 51.44%. The 1 year total shareholder return of 30.95% points to momentum that has...

TKO Group Holdings (TKO) drew fresh attention after releasing second quarter 2026 results, raising full year revenue guidance, and updating investors on progress with its multi year share repurchase program. See our latest analysis for TKO Group Holdings. The share price reaction has been positive in the short term, with a 7 day share price return of 7.89% and a 30 day gain of 8.39%, while the year to date share price return is still down 2.74%. Over longer horizons, total shareholder return...

Freshpet, Inc. reported its second-quarter 2026 results in early August, with sales of US$305.59 million and net income of US$19.49 million, alongside higher earnings per share versus the prior year period. Management paired these results with a higher 2026 net sales growth outlook and confirmed expectations for 2027 sales to outpace overall category expansion, underlining confidence in its growth trajectory. We’ll now examine how Freshpet’s raised 2026 net sales growth guidance reshapes the...

Inhibrx Biosciences, Inc. reported second-quarter 2026 results, with net loss widening to US$36.65 million and basic loss per share from continuing operations at US$2.34, while first-half losses were broadly similar to the prior year. Alongside these figures, the company highlighted FDA acceptance of its biologics license application for ozekibart in conventional chondrosarcoma, setting a PDUFA goal date of April 14, 2027, and pointed to upcoming Phase 2 data for INBRX-106 in head and neck...

In early August 2026, Exelixis reported past second-quarter results showing revenue of US$628.69 million and net income of US$212.05 million, while slightly trimming its full-year 2026 revenue outlook to US$2.50 billion–US$2.55 billion and filing a US$112 million employee stock plan-related shelf registration. Alongside these financial updates, Exelixis highlighted continued progress of its oncology pipeline, including zanzalintinib as a potential second franchise, reinforcing its effort to...

Vaxcyte, Inc. recently reported second-quarter 2026 results showing a wider net loss of US$284.3 million and higher basic loss per share, while also updating investors on the progress of its vaccine pipeline. Alongside the larger first-half loss of US$604.92 million, management highlighted full enrollment of three pivotal VAX-31 adult Phase 3 trials and early-stage progress for VAX-A1 against Group A Streptococcus, underscoring the company’s heavy investment in late- and early-stage vaccine...

Perrigo Company plc recently reported its second-quarter 2026 results, with sales of US$1,022.8 million and net income of US$74.5 million, and reaffirmed full-year 2026 guidance calling for an All In net sales decline of between 5.5% and 1.5%. The quarter marked a shift from a net loss a year earlier to positive earnings per share, even as both quarterly and year-to-date sales fell compared with 2025 and the company remained loss-making over the first half. We’ll now examine how Perrigo’s...

Fidelity National Financial recently reported past second-quarter 2026 results, with revenue of US$4,051 million and net income of US$288 million, alongside a quarterly dividend declaration of US$0.52 per share payable on September 30, 2026. The combination of stronger earnings driven by commercial transaction activity, disciplined cost control, and ongoing share repurchases highlights management’s emphasis on both operational efficiency and direct capital returns to shareholders. Next,...

Janus Living (JAN) has completed a $464 million follow on equity offering of 16,000,000 Class A 1 common shares at $29 each, reflecting a discount of $1.0875 per share. See our latest analysis for Janus Living. Janus Living shares have gained momentum in recent months, with a 14.8% 90 day share price return and 29.8% year to date share price return, as investors respond to stronger earnings, raised 2026 guidance and the completed equity raise. If this kind of activity has your attention, it...

In August 2026, USA TODAY Sports launched USA TODAY Sports Fantasy, a US$39.99-per-year fantasy football subscription platform, while Golfweek partnered with REMAX Golf Lifestyles to create a free golf real estate and lifestyle hub for its 2 million monthly users. Together, these moves show USA TODAY expanding beyond traditional news into subscription-based fantasy tools and niche lifestyle experiences that deepen audience engagement. Next, we’ll examine how the new USA TODAY Sports Fantasy...

Earlier this week, Welltower Inc. declared a US$0.85 cash dividend with an ex-date of August 12, 2026, while continuing to focus on rental housing for aging seniors across the US, UK, and Canada. Separately, Baron Opportunity Fund’s decision in Q2 2026 to add Welltower, citing its data-driven operating platform and technology focus, highlights growing institutional interest in the company’s ability to enhance margins and occupancy in senior housing. Next, we’ll examine how Baron Opportunity...

International General Insurance Holdings Ltd. reported past second-quarter 2026 results showing revenue of US$143.5 million but lower net income of US$20.9 million versus the prior year, while its Board declared a US$0.075 per-share dividend payable on September 2, 2026 to shareholders of record on August 18, 2026. Alongside these earnings and dividend actions, the company also disclosed completion of a share repurchase program totaling 1,094,445 shares for US$26.33 million, underlining its...

Forte Biosciences, Inc. reported past second-quarter and first-half 2026 results, with net losses of US$23.33 million and US$45.47 million respectively, both higher than the prior-year periods. Despite the larger overall losses, basic loss per share from continuing operations narrowed slightly to US$2.18 from US$2.32 a year earlier, highlighting the impact of share count and capital structure on per-share results. Next, we’ll examine how the widening net loss alongside a slightly improved...

Galaxy Digital (NasdaqGS:GLXY) and Bank Leumi announced a partnership to offer regulated digital asset trading services to Israeli customers. The collaboration positions Bank Leumi as the first major Israeli bank to provide access to cryptocurrencies under local regulatory oversight. Galaxy Digital will supply its GalaxyOne Institutional and Custody Infrastructure platforms to support trading and asset safekeeping for the bank and its clients. This move extends Galaxy Digital's presence in...

Lantheus Holdings (NasdaqGM: LNTH) received FDA approval for TAUKLARIFY, a tau PET imaging agent for Alzheimer's disease diagnostics. The approval adds a new Alzheimer's focused product to Lantheus' molecular imaging portfolio. TAUKLARIFY is intended to help visualize tau pathology in the brain, supporting more precise assessment of Alzheimer's disease. For readers tracking how new diagnostic tools could intersect with drug development and data driven care, the broader trend in healthcare...

In recent months, Markel Group has reported softer quarterly results, with net premiums earned staying flat over the past two years and trailing broader insurance peers. An important insight is that sell-side analysts now expect Markel Group’s revenue to decline over the next year, highlighting potential demand pressures across its offerings. We’ll now examine how these expectations of weaker revenue, alongside flat premiums, may influence Markel Group’s existing investment narrative. AI is...

Estée Lauder Companies (NYSE: EL) announced a research collaboration with the University of Leeds and Dr. Kaida Xiao focused on advanced color science for complexion products. The partnership aims to improve shade matching accuracy in luxury foundations and related complexion lines using visual perception science. The work is expected to inform future formula development and product testing in the prestige cosmetics segment. For investors tracking how advanced data and perception science...

Inspire Medical Systems (INSP) stock is back in focus after the company released second quarter 2026 results and updated its full year guidance on 3 August, along with an update on its share repurchase activity. See our latest analysis for Inspire Medical Systems. Despite Inspire Medical Systems updating guidance and completing its buyback program, the stock’s recent momentum has cooled, with the 1-day and 7-day share price returns down 1.89% and 5.09%. This contrasts with a 90-day share...

Avnet stock has delivered a strong 174.0% return over the past 5 years, yet its low overall value score and rich recent run leave investors weighing how much upside is already reflected in the price. Avnet has returned 174.0% over 5 years, which puts recent gains front and center when assessing how much future return potential may be left. Recent enthusiasm around Avnet's AI related industrial automation work with partners can support growth expectations, while any setback in these projects...

Immunovant (IMVT) has drawn fresh attention after management outlined progress and plans for its anti FcRn therapy IMVT-1402, highlighting upcoming clinical readouts, regulatory milestones through 2028, and readiness for potential commercial launches. See our latest analysis for Immunovant. At a share price of US$41.82, Immunovant has seen solid momentum build, with a 90 day share price return of 52.13% and a 1 year total shareholder return of 174.77%, as investors respond to IMVT-1402...

Pinnacle Financial Partners (PNFP) continues to draw investor attention after its recent share price move, with the stock last closing at $108.01. That puts the bank's market value at about $16.1b. See our latest analysis for Pinnacle Financial Partners. The recent 8.22% 1 month share price return and 14.88% 3 month share price return suggest building momentum for Pinnacle Financial Partners, while the 19.18% 1 year total shareholder return highlights a solid longer term outcome for...